Promoters Samina, Rumana Hamied exit Cipla by selling 1.72 percent stake
New Delhi: Samina Hamied and Rumana Hamied, promoters of the Indian pharmaceutical giant Cipla, have sold their 1.72 percent stake in the company for Rs 2,111 crore through open market transactions.
According to block deal data available on the National Stock Exchange (NSE), Samina Hamied sold 89.54 lakh shares of Cipla, amounting to 1.11 percent stake, while Rumana Hamied offloaded 49.43 lakh shares, representing 0.61 percent stake. The transactions mark their exit from the company.
Singapore government, Societe Generale, Abu Dhabi Investment Authority, BNP Paribas, BofA Securities, Citigroup, Morgan Stanley, Goldman Sachs, Norges Bank, UBS, and Copthall Mauritius bought stakes in Cipla.
Read also: Cipla, Alkem vie for Rs 4,000 crore stake in India's largest stent manufacturer: Report
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.